MELBOURNE’S ROYAL CHILDREN’S HOSPITAL PURCHASES IMRIScardio
SYSTEM

-- First paediatric hospital in the world to have IMRIScardio capabilities --

WINNIPEG, Oct. 28 /CNW/ - (TSX: IM) - IMRIS Inc. ("IMRIS" or the "Company") today announced the sale of IMRIScardio to The Royal Children's Hospital ("RCH") in Melbourne Australia making it the first paediatric hospital in the world with the capabilities of both IMRIScardio and IMRISneuro.

The Royal Children's Hospital is internationally recognized as a leading centre for paediatrics and is the Australian National Centre for cardiac transplantation. The IMRIS suite at the RCH will combine the value of IMRIScardio and IMRISneuro and provide multi-modality image guidance capabilities to assist clinicians in improving outcomes for patients. The fully integrated suite will include an interventional theatre for cardiovascular procedures, an operating room for neurosurgery and a diagnostic centre.

"The introduction of intra-operative MRI at The Royal Children's Hospital, Melbourne will increase imaging accuracy and safety for patients requiring neurosurgery, and cardiac investigations and procedures. This will not only improve patient outcomes, but enhance RCH Medical Imaging's reputation as a centre of excellence," RCH CEO Professor Christine Kilpatrick said.

The leading edge IMRIS system features an advanced bi-plane angiography system in the interventional theatre and a wide bore 3T MR scanner. The high-field MR scanner can be deployed into any of the three rooms, permitting rapid and efficient transitions between MR imaging and surgery or intervention without transporting the patient between modalities. MR images can be taken before, during and after procedures and can also be used in conjunction with fluoroscopic images during cardiovascular procedures. When not in use for intra operative imaging, both the MR and fluoroscopic system are available for diagnostic use.

No other system offers the same degree of safety for both the patient and the surgical environment. The IMRIS system does not require the patient to be transported for scanning, so the optimum position for surgical and interventional procedures is ensured. Clinical workflow and surgical access to the patient is maintained and the MR scanner is removed completely from the operating room when scanning is complete.

"The IMRIS system is the first solution in the world that allows the capabilities of both MRI and x-ray angiography in a single suite without having to move the patient between modalities," said David Graves, IMRIS Chairman and CEO. "We are looking forward to getting IMRIScardio installed, and confident that the new system will play an important role in supporting the RCH's tradition of delivering high calibre, leading edge paediatric care."

The IMRIS system will be installed in the new $AU 1 billion Royal Children's Hospital that is currently under construction. This world-class facility is expected to be completed in 2011.

About The Royal Children's Hospital

The Royal Children's Hospital Melbourne is internationally recognized as a leading centre of paediatric treatment, teaching and research. RCH is the major specialist paediatric hospital in Victoria and extends care to children from Tasmania, southern New South Wales and other states around Australia and overseas. RCH is the designated statewide major trauma centre for paediatrics in Victoria and a Nationally Funded Centre for cardiac and liver transplantation.

About IMRIS

IMRIS (TSX: IM) is a global leader in providing image guided therapy solutions. These solutions feature fully integrated surgical and interventional suites that incorporate magnetic resonance, fluoroscopy and computed tomography to deliver on demand imaging during procedures. The Company's systems serve the neurosurgical, cardiovascular and neurovascular markets and have been selected by leading medical institutions around the world.

For further information:

Brad Woods
Director Investor Relations
& Corporate Communications
IMRIS Inc.
Tel: [phone]
Email: [email protected]